Stay updated on RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.

Latest updates to the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference1%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now indicates that the ClinicalTrials.gov data ingest is expected to be modernized in July 2025, with specific dates for input from API users. Additionally, the mention of Reata as a subsidiary of Biogen has been clarified.SummaryDifference4%
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check52 days agoChange DetectedThe page has removed a citation regarding the erratum for the MOXIe Study, which may affect the credibility of the information presented about the study's findings.SummaryDifference0.3%
Stay in the know with updates to RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.